Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A staging of lymphomas: practical thoughts on impractical practices.

A Raubitschek1, T Goffman, E Glatstein

  • 1Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20892.

Journal of the National Cancer Institute. Monographs
|January 1, 1990
PubMed
Summary

Lymphoma staging differs from other cancers, focusing on evaluating treatment programs rather than individual patient care. Consistent standards are crucial for comparing treatment outcomes across studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast-tumor xenograft targeting and therapy studies using radiolabeled chimeric anti-cea monoclonal-antibody t84.66.

Oncology reports·2011
Same author

TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions.

Bone marrow transplantation·2010
Same author

[Vancomycin-resistant enterococci: prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Niños de Córdoba].

Revista Argentina de microbiologia·2009
Same author

Intraperitoneal photodynamic therapy.

Cancer treatment and research·2007
Same author

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation.

Bone marrow transplantation·2006
Same author

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma.

Bone marrow transplantation·2005

Area of Science:

  • Oncology
  • Hematology
  • Clinical Research

Background:

  • Lymphoma staging serves a distinct purpose compared to other cancer types.
  • It is primarily used for evaluating treatment program efficacy, not individual patient management.
  • Accurate comparison of treatment outcomes requires careful consideration of staging methodologies.

Purpose of the Study:

  • To highlight the unique role of lymphoma staging in clinical research.
  • To emphasize the importance of standardized staging for treatment evaluation.
  • To identify common pitfalls in lymphoma staging and treatment comparison.

Main Methods:

  • Review of lymphoma staging principles and their application in clinical trials.
  • Analysis of common errors in comparing staging methods (surgical vs. clinical).

Related Experiment Videos

  • Discussion of the impact of advanced diagnostic techniques on staging and outcome interpretation.

    • Main Results:

    • Lymphoma staging's primary utility is in assessing treatment program changes.
    • Inconsistent staging standards can lead to erroneous comparisons between studies.
    • Introduction of new diagnostic tests may cause 'upstaging' without altering overall treatment effectiveness.

    Conclusions:

    • Lymphoma staging is a critical tool for evaluating treatment evolution and establishing research benchmarks.
    • Researchers must ensure comparability of study groups by adhering to consistent staging criteria.
    • Awareness of diagnostic advancements and their impact on staging is essential for accurate clinical research interpretation.